Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome
P Rodriguez-Viciana, O Tetsu, WE Tidyman, AL Estep… - Science, 2006 - science.org
Science, 2006•science.org
Cardio-facio-cutaneous (CFC) syndrome is a sporadic developmental disorder involving
characteristic craniofacial features, cardiac defects, ectodermal abnormalities, and
developmental delay. We demonstrate that heterogeneous de novo missense mutations in
three genes within the mitogen-activated protein kinase (MAPK) pathway cause CFC
syndrome. The majority of cases (18 out of 23) are caused by mutations in BRAF, a gene
frequently mutated in cancer. Of the 11 mutations identified, two result in amino acid …
characteristic craniofacial features, cardiac defects, ectodermal abnormalities, and
developmental delay. We demonstrate that heterogeneous de novo missense mutations in
three genes within the mitogen-activated protein kinase (MAPK) pathway cause CFC
syndrome. The majority of cases (18 out of 23) are caused by mutations in BRAF, a gene
frequently mutated in cancer. Of the 11 mutations identified, two result in amino acid …
Cardio-facio-cutaneous (CFC) syndrome is a sporadic developmental disorder involving characteristic craniofacial features, cardiac defects, ectodermal abnormalities, and developmental delay. We demonstrate that heterogeneous de novo missense mutations in three genes within the mitogen-activated protein kinase (MAPK) pathway cause CFC syndrome. The majority of cases (18 out of 23) are caused by mutations in BRAF, a gene frequently mutated in cancer. Of the 11 mutations identified, two result in amino acid substitutions that occur in tumors, but most are unique and suggest previously unknown mechanisms of B-Raf activation. Furthermore, three of five individuals without BRAF mutations had missense mutations in either MEK1 or MEK2, downstream effectors of B-Raf. Our findings highlight the involvement of the MAPK pathway in human development and will provide a molecular diagnosis of CFC syndrome.
AAAS